Table 2.
Participants’ demographics, body mass index, and pre-COVID vaccination status.
| Time to viral RNA clearance from the URT >28 days from acute COVID-19 onset (n = 30) | Time to viral RNA clearance from the URT ≤28 days from acute COVID-19 onset (n = 43) | ||
|---|---|---|---|
| Age at enrollment, median (IQR), years | 54 (46-65) | 50 (40-58) | |
| Female, no. (%) | 18 (60) | 28 (65) | |
| Race and ethnicity, no. (%) | Non-Hispanic African American | 9 (30) | 11 (26) |
| Non-Hispanic White | 15 (50) | 23 (53) | |
| Non-Hispanic other | 1 (3) | 2 (5) | |
| Hispanic | 5 (17) | 7 (16) | |
| BMI ≥ 25 kg/m2, no. (%) | 25 (83) | 29 (67) | |
| Prior diagnosis of hypertension, no. (%) | 14 (47) | 12 (28) | |
| Prior diagnosis of diabetes, no. (%) | 7 (23) | 6 (14) | |
| Prior diagnosis of anxiety, depression, or bipolar, no. (%) | 5 (17) | 15 (35) | |
| Median time to viral RNA clearance (IQR), days | 74 (37-132) | 16 (14-21) | |
| Hospitalized during acute COVID-19, no. (%) | 2 (7) | 0 (0) | |
| COVID vaccination status prior to COVID-19, no. (%) | No vaccine doses | 29 (97) | 30 (70) |
| Incomplete primary vaccination series | 0 (0) | 4 (9) | |
| Complete primary vaccination series | 1 (3) | 9 (21) |
URT, upper respiratory tract encompassing mid-turbinate nasal swab and saliva; BMI, body mass index.